Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

被引:216
作者
Ostapowicz, G
Watson, KJR
Locarnini, SA
Desmond, PV
机构
[1] St Vincents Hosp, Dept Gastroenterol, Fitzroy, Vic 3065, Australia
[2] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
关键词
D O I
10.1002/hep.510270637
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In patients with chronic hepatitis C, alcohol consumption has been proposed as a risk factor for the progression of liver disease; however, evidence for this remains conflicting. Two hundred thirty-four anti-hepatitis C virus (HCV)-positive patients who had a liver biopsy performed within the past 24 months were studied. Demographic data and information on risk factors were recorded, A detailed lifetime alcohol consumption history was obtained. Viral studies included HCV viral titer and HCV genotype, Mean age (+/- SEM) of the group was 40.8 +/- 0.7 years. One hundred sixty-six (71%) were male. A risk factor for HCV infection was found in 195 patients (86%). Genotype distribution was: Ib: 22%; la: 15%; 1(nonsubtypable): 15%; 3a: 34%; and 2: 7%. Fifty (21%) patients had cirrhosis, Patients with cirrhosis were older (51.6 +/- 1.8 years) than those with chronic hepatitis (37.6 +/- 0.6 years; P = .0001), were infected at an older age (25.9 +/- 2.0 vs. 20.9 +/- 0.6 years; P = .001), and had a longer duration of infection (20.5 +/- 1.3 vs. 16.2 +/- 0.5 years; P = .0008). Patients with cirrhosis had a greater total lifetime alcohol consumption (288,765 +/- 58,115; g) than those with chronic hepatitis (189,941 +/- 15,453 g; P = .018). Cirrhotic patients also had greater total alcohol consumption during the period of infection with HCV (240,962 +/- 63,756 g vs. 146,510 +/- 12,862 g; P = .02), On multivariate analysis, subject age and total alcohol consumption were independently associated with the presence of cirrhosis, Total lifetime alcohol consumption is a risk factor for the progression of liver disease caused by HCV.
引用
收藏
页码:1730 / 1735
页数:6
相关论文
共 36 条
  • [11] IRON STORAGE, LIPID-PEROXIDATION AND GLUTATHIONE TURNOVER IN CHRONIC ANTI-HCV POSITIVE HEPATITIS
    FARINATI, F
    CARDIN, R
    DEMARIA, N
    DELLALIBERA, G
    MARAFIN, C
    LECIS, E
    BURRA, P
    FLOREANI, A
    CECCHETTO, A
    NACCARATO, R
    [J]. JOURNAL OF HEPATOLOGY, 1995, 22 (04): : 449 - 456
  • [12] QUANTITATION OF HEPATITIS-C VIRUS-RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS AND PATIENTS WITH TYPE-C CHRONIC LIVER-DISEASE
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    NAITO, M
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. HEPATOLOGY, 1993, 17 (04) : 545 - 550
  • [13] Iron overload in patients with chronic hepatitis C: A clinicopathologic study
    Haque, S
    Chandra, B
    Gerber, MA
    Lok, ASF
    [J]. HUMAN PATHOLOGY, 1996, 27 (12) : 1277 - 1281
  • [14] Serum HCV RNA levels assessed by quantitative NASBA(R): Stability of viral load over time, and lack of correlation with liver disease
    Hollingsworth, RC
    Sillekens, P
    vanDeursen, P
    Neal, KR
    Irving, WL
    [J]. JOURNAL OF HEPATOLOGY, 1996, 25 (03) : 301 - 306
  • [15] Holtzmuller K, 1996, HEPATOLOGY, V24, P1009
  • [16] HONDA M, 1994, HEPATOLOGY, V20, P1144, DOI 10.1002/hep.1840200507
  • [17] IZOPET J, 1994, HEPATOLOGY, V20, pA241
  • [18] QUANTIFICATION OF HEPATITIS-C VIRUS BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION - INCREASE OF THE VIRUS IN ADVANCED LIVER-DISEASE
    KATO, N
    YOKOSUKA, O
    HOSODA, K
    ITO, Y
    OHTO, M
    OMATA, M
    [J]. HEPATOLOGY, 1993, 18 (01) : 16 - 20
  • [19] FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS
    KNODELL, RG
    ISHAK, KG
    BLACK, WC
    CHEN, TS
    CRAIG, R
    KAPLOWITZ, N
    KIERNAN, TW
    WOLLMAN, J
    [J]. HEPATOLOGY, 1981, 1 (05) : 431 - 435
  • [20] NON-A, NON-B POSTTRANSFUSION HEPATITIS - LOOKING BACK IN THE 2ND DECADE
    KORETZ, RL
    ABBEY, H
    COLEMAN, E
    GITNICK, G
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) : 110 - 115